Colo. Pharma Co. Faces Securities Suit Over Drug Claims
Colorado pharmaceutical company Ampio is facing a proposed shareholder class action accusing the firm's executives of making false and misleading claims about the efficacy of its star drug, Ampion, which it...To view the full article, register now.
Already a subscriber? Click here to view full article